Benign Prostatic Hyperplasia
📧 Sign up to get email alerts when something new happens for Benign Prostatic Hyperplasia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-07-07FDA Approved: DOXAZOSIN — Original Application (Zydus Lifesciences Limited)
FDA approved the original application for generic doxazosin from Zydus Lifesciences Limited. This product provides a generic option for the …
-
FDA approval · 2017-06-26FDA Approved: TAMSULOSIN HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Tamsulosin hydrochloride from Macleods Pharmaceuticals Limited (ANDA 204645).
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: Bioequivalence - Duodart Against Avodart & Omnic [Phase 1]
A Phase 1 bioequivalence trial comparing Duodart to Avodart and Omnic has completed in benign prostatic hyperplasia.
-
CLINICAL_TRIALS research · 2017-06-14Clinical Trial Update: Sexual Steroids: Relationship Between Serum and Prostatic Tissue Level [NA]
This clinical trial update reports on a study evaluating the relationship between serum levels of sexual steroids and their concentrations i…
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry. [Phase 1]
Phase 1 study evaluating the relative bioavailability of a fixed-dose combination tablet of dutasteride 0.5 mg and tamsulosin hydrochloride …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA) [Phase 3]
Phase 3 trial update evaluating levofloxacin for management of patients with abnormal PSA. The study includes conditions such as benign pros…
-
CLINICAL_TRIALS research · 2017-05-30Clinical Trial Update: Economic Analyses of the REDUCE Trial
This document reports economic analyses based on the REDUCE trial, evaluating the cost-effectiveness and economic impact of dutasteride in m…
-
CLINICAL_TRIALS trial_result · 2017-05-22Clinical Trial Update: Benefits of Adherence to 5-alpha Reductase Inhibitor Treatment in Men With Enlarged Prostate: An Assessment of Medicare and Medicaid Patients Using the MarketScan Database
A real-world study using Medicare, Medicaid and MarketScan data assesses whether adherence to 5-alpha reductase inhibitor therapy in men wit…
-
CLINICAL_TRIALS trial_result · 2017-05-22Clinical Trial Update: Korean Practice Patterns for Screening PCA(Prostate Cancer)
This completed clinical trial update covers a study on Korean practice patterns for screening prostate cancer, sponsored by GlaxoSmithKline,…
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of S-Equol for benign prostatic hyperplasia has completed, with results posted i…
-
CLINICAL_TRIALS research · 2017-05-18Clinical Trial Update: Digital Rectal Exam Proficiency Tool
An update on a University of Virginia-sponsored clinical trial evaluating a digital rectal exam proficiency tool, related to benign prostati…
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: Clinical Progression and Costs in Benign Prostatic Hyperplasia Patients Treated With Early Versus Delayed Combination Therapy
This completed clinical trial compared early versus delayed combination therapy in Benign Prostatic Hyperplasia and examined clinical progre…
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Safety and Efficacy Study for the Treatment of BPH (Enlarged Prostate) [NA]
Clinical trial update reporting safety and efficacy for a Benign Prostatic Hyperplasia treatment; study completed with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: The Effects of α-adrenergic Receptor Antagonists on Choroid and Pupil [Phase 4]
Phase 4 clinical trial evaluating the effects of α-adrenergic receptor antagonists on the choroid and pupil; the study status is completed.
-
FDA approval · 2017-05-05FDA Approved: CIALIS — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Cialis (tadalafil) submitted by Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2017-04-27Clinical Trial Update: Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH [Phase 3]
A Phase 3 randomized, double-blind study evaluating the safety and efficacy of intraprostatic PRX302 for lower urinary tract symptoms due to…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: A Study to Investigate the Pharmacokinetic Drug Interactions Between Dutasteride and Tadalafil in Healthy Male Subjects [Phase 1]
Phase 1 study to evaluate the pharmacokinetic interactions between dutasteride and tadalafil in healthy male subjects.
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: A Trial Assessing Peri-procedure Chemoprophylaxis During Transrectal Prostate Needle Biopsy [Phase 4]
Phase 4 clinical trial, sponsored by Mansoura University, evaluating peri-procedure chemoprophylaxis during transrectal prostate needle biop…
-
CLINICAL_TRIALS research · 2017-03-31Clinical Trial Update: The Influence of Benign Prostatic Hyperplasia on Bladder Function
This document notes an ongoing investigation into how benign prostatic hyperplasia influences bladder function.
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic Hyperplasia [Phase 4]
Phase 4 trial evaluating silodosin for nocturia in men with benign prostatic hyperplasia has completed, reporting on efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018 [Phase 3]
A Phase 3 clinical trial (NX02-0018) evaluating NX-1207 for benign prostatic hyperplasia has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022) [Phase 3]
Phase 3 trial evaluating re-injection of NX-1207 for benign prostatic hyperplasia has completed.
-
FDA approval · 2017-03-08FDA Approved: FINASTERIDE — Supplemental Application (Ascend Laboratories, LLC)
FDA approves a supplemental application for finasteride filed by Ascend Laboratories, LLC under an ANDA.
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS). [Phase 4]
Phase 4 trial evaluating tadalafil (LY450190) for lower urinary tract symptoms due to benign prostatic hyperplasia has completed, with resul…
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Clinical Results of Odyliresin (Iresine Celosia) in Symptomatic Benign Prostatic Hyperplasia [NA]
This update presents the clinical results of the experimental drug Odyliresin for symptomatic benign prostatic hyperplasia from a completed …